Egyptian Board Thoracic Diseases study materials
Egyptian Board Thoracic Diseases study resources

Egyptian Board Thoracic Diseases flashcards

Egyptian Board Thoracic Diseases · Build recall with a focused review session.

32 cards. Read the term and the definition here. The deck at the top of this page is optional.

Alveolar gas equation
PAO2 = FiO2(PB − 47) − PaCO2/0.8. At sea level on room air, PAO2 ≈ 150 − PaCO2/0.8; used to calculate A-a gradient and assess hypoxemia mechanism.
A-a gradient
Difference between alveolar and arterial oxygen tension. Normal ≈ age/4 + 4 mmHg. Widened in V/Q mismatch, shunt, or diffusion limitation; normal in pure hypoventilation.
Oxygen content formula
CaO2 = 1.34 × Hb × SaO2 + 0.003 × PaO2. Dissolved oxygen contributes minimally at atmospheric pressure; anemia reduces content despite normal saturation.
West lung zones
Zone 1 apex: PA > Pa > Pv, dead space. Zone 2 middle: Pa > PA > Pv, Starling resistor. Zone 3 base: Pa > Pv > PA, perfusion. Explains V/Q heterogeneity.
Spirometry obstruction criterion
Post-bronchodilator FEV1/FVC < 0.70 or below lower limit of normal defines obstructive defect; severity graded by FEV1 % predicted.
Bronchodilator response
Increase in FEV1 or FVC of ≥12% and ≥200 mL after bronchodilator. Indicates reversible airflow limitation, supporting asthma diagnosis.
Light's criteria
Pleural fluid is exudate if protein ratio >0.5, LDH ratio >0.6, or LDH >2/3 upper normal serum. Sensitivity high; misclassifies some transudates.
EBUS-TBNA
Endobronchial ultrasound-guided transbronchial needle aspiration for mediastinal lymph node sampling; sensitivity >90% for lung cancer staging, avoiding mediastinoscopy.
GOLD ABE groups
COPD classification: A = 0–1 exacerbations, mMRC 0–1; B = 0–1 exacerbations, mMRC ≥2; E = ≥2 moderate or ≥1 hospitalization. Guides inhaled therapy.
Long-term oxygen therapy criteria
COPD with PaO2 ≤55 mmHg or SaO2 ≤88%, or PaO2 56–59 with cor pulmonale or polycythemia. Use ≥15 h/day to improve survival.
Bronchiectasis signet-ring sign
HRCT finding of dilated bronchus with adjacent pulmonary artery, indicating bronchiectasis. Airway clearance and targeted antibiotics are mainstays.
CURB-65
CAP severity score: confusion, urea >7 mmol/L, respiratory rate ≥30, blood pressure <90/60, age ≥65. Score ≥2 consider admission; ≥3 assess ICU.
Xpert MTB/RIF
Rapid molecular test detecting Mycobacterium tuberculosis and rifampicin resistance in sputum; high sensitivity and specificity; culture remains gold standard.
Aspergilloma
Fungal ball in pre-existing lung cavity, often from prior TB; causes hemoptysis. Treat with surgical resection or bronchial artery embolization.
Pneumocystis jirovecii pneumonia
Opportunistic infection in immunocompromised patients; ground-glass opacities, elevated LDH and beta-D-glucan. First-line treatment is trimethoprim-sulfamethoxazole.
IPF treatment
Idiopathic pulmonary fibrosis with usual interstitial pneumonia pattern; treat with pirfenidone or nintedanib to slow progression. Immunosuppression is not recommended.
Löfgren syndrome
Acute sarcoidosis triad: fever, erythema nodosum, arthritis, with bilateral hilar lymphadenopathy. Usually self-limited with good prognosis.
Silicosis
Occupational lung disease from silica inhalation; upper-lobe nodular fibrosis, eggshell hilar calcification; increased risk of tuberculosis and autoimmune disease.
Wells score for PE
Clinical probability score: >6 high, 2–6 moderate, <2 low. Combined with D-dimer to rule out PE in low or intermediate probability.
CTEPH
Chronic thromboembolic pulmonary hypertension: persistent dyspnea after PE. V/Q scan is screening; pulmonary endarterectomy is potentially curative.
OSA diagnosis
Apnea-hypopnea index ≥5 with symptoms or ≥15 regardless of symptoms on polysomnography. CPAP is first-line therapy.
Lung cancer molecular testing
For non-small cell lung cancer, test EGFR, ALK, ROS1, and PD-L1 before first-line systemic therapy to guide targeted treatment.
Malignant pleural effusion
Pleural fluid cytology sensitivity ~60%; thoracoscopy improves yield. Palliate with indwelling pleural catheter or pleurodesis.
Tension pneumothorax
Life-threatening pneumothorax with hemodynamic compromise; immediate needle decompression followed by chest tube. Do not delay for imaging.
ARDS Berlin definition
Acute onset within 1 week, bilateral opacities, PEEP ≥5, PaO2/FiO2 ≤300. Severity: mild 200–300, moderate 100–200, severe <100.
Lung-protective ventilation
Tidal volume 6 mL/kg predicted body weight, plateau pressure ≤30 cmH2O, driving pressure ≤15. Reduces mortality in ARDS.
Rapid shallow breathing index
Respiratory rate divided by tidal volume in liters; <105 predicts successful weaning from mechanical ventilation during spontaneous breathing trial.
Pediatric croup treatment
Dexamethasone for all severities; nebulized adrenaline for severe stridor. Barking cough and inspiratory stridor are typical.
Cystic fibrosis sweat test
Sweat chloride ≥60 mmol/L on two occasions confirms CF; 30–59 mmol/L is intermediate. Newborn screening uses immunoreactive trypsinogen.
Primary ciliary dyskinesia
Situs inversus, chronic rhinosinusitis, bronchiectasis; nasal nitric oxide <77 nL/min is supportive. Autosomal recessive inheritance.
Number needed to treat
NNT = 1/absolute risk reduction. Indicates how many patients need treatment for one additional benefit; lower NNT means greater effect.
GRADE system
Rates certainty of evidence and strength of recommendations; considers risk of bias, inconsistency, indirectness, imprecision, and publication bias.